D
Sell
2/23/2024Upgraded
2seventy bio, Inc. (TSVT) was upgraded to D- from E+ on 2/23/2024 due to an increase in the volatility index.
E
Sell
9/14/2023Downgrade
2seventy bio, Inc. (TSVT) was downgraded to E+ from D- on 9/14/2023 due to a decline in the volatility index and total return index.
D
Sell
8/30/2023Upgraded
2seventy bio, Inc. (TSVT) was upgraded to D- from E+ on 8/30/2023 due to an increase in the volatility index.
E
Sell
8/15/2023Downgrade
2seventy bio, Inc. (TSVT) was downgraded to E+ from D- on 8/15/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
3/14/2023Downgrade
2seventy bio, Inc. (TSVT) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
2seventy bio, Inc. (TSVT) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
2seventy bio, Inc. (TSVT) was downgraded to D- from D on 02/08/2023.
D
Sell
12/1/2022Upgraded
2seventy bio, Inc. (TSVT) was upgraded to D from D- on 12/1/2022 due to a substantial increase in the growth index and total return index. Earnings per share increased from -$2.0171 to -$1.7598, and EBIT increased 11.15% from -$76.89M to -$68.32M.
D
Sell
8/1/2022Upgraded
2seventy bio, Inc. (TSVT) was upgraded to D- from E on 8/1/2022 due to a large increase in the efficiency index, solvency index and volatility index. Debt to equity declined from 0.03 to 0.02, the quick ratio increased from 2.87 to 3.71, and total capital increased 13.2% from $642.04M to $726.77M.
E
Sell
5/1/2022Upgraded
2seventy bio, Inc. (TSVT) was upgraded to E from E- on 5/1/2022 due to a significant increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.15 to 2.87.
E
Sell
1/28/2022None
2seventy bio, Inc. (TSVT) was downgraded to E- from U on 01/28/2022.
